• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The extravascular implantable defibrillator: a novel opportunity for the paediatric population.

作者信息

Biffi Mauro, Quaranta Andrea, Carecci Alessandro, Ragni Luca, Donti Andrea, Martignani Cristian, Diemberger Igor, Angeletti Andrea, Ziacchi Matteo

机构信息

IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy.

Dipartimento di Scienze Mediche e Chirurgiche, Istituto di Cardiologia, Università di Bologna, 40138 Bologna, Italy.

出版信息

Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf128.

DOI:10.1093/europace/euaf128
PMID:40567174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12287921/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f137/12287921/eedbfc35b240/euaf128f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f137/12287921/eedbfc35b240/euaf128f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f137/12287921/eedbfc35b240/euaf128f1.jpg

相似文献

1
The extravascular implantable defibrillator: a novel opportunity for the paediatric population.血管外植入式除颤器：儿科人群的新机遇。
Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf128.
2
Left Ventricular Assist Device Implantation in the Presence of Substernal Extravascular Implantable Cardioverter-Defibrillator.在胸骨后血管外植入式心脏复律除颤器存在的情况下进行左心室辅助装置植入术。
JACC Case Rep. 2025 Jun 4;30(13):103508. doi: 10.1016/j.jaccas.2025.103508.
3
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.经长期随访的血管外植入式心脏复律除颤器的性能与安全性：关键研究的最终结果
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
4
Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.患者对生命末期植入式心脏复律除颤器停用的看法。
Palliat Med. 2015 Apr;29(4):310-23. doi: 10.1177/0269216314550374. Epub 2014 Sep 19.
5
Temporal trends in population characteristics and type of device among primary prevention implantable cardioverter defibrillator recipients: The DAI-PP programme.原发性预防植入式心脏复律除颤器接受者的人口特征和设备类型的时间趋势：DAI-PP项目
Arch Cardiovasc Dis. 2025 Mar;118(3):178-184. doi: 10.1016/j.acvd.2024.10.335. Epub 2025 Jan 23.
6
Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease: a single-center experienced based study.复杂先天性心脏病中皮下植入式心律转复除颤器与起搏器联合装置：一项基于单中心经验的研究
J Interv Card Electrophysiol. 2023 Oct 25. doi: 10.1007/s10840-023-01670-1.
7
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial.长期随访期间经静脉与皮下植入式心律转复除颤器治疗的器械相关并发症：PRAETORIAN-XL试验
Circulation. 2025 Jul 22;152(3):172-182. doi: 10.1161/CIRCULATIONAHA.125.074576. Epub 2025 Apr 25.
8
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular Tachyarrhythmias.在植入式心脏复律除颤器和先前的室性心律失常患者中，与性别相关的室性心律失常事件的差异。
JACC Clin Electrophysiol. 2024 Feb;10(2):284-294. doi: 10.1016/j.jacep.2023.09.028. Epub 2023 Nov 29.
9
Extravascular Implantable Cardioverter-Defibrillators: A Systematic Review of Emerging Evidence.血管外植入式心脏复律除颤器：新证据的系统评价
Cureus. 2025 Jun 4;17(6):e85359. doi: 10.7759/cureus.85359. eCollection 2025 Jun.
10
Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.患者、亲密伴侣和家属对植入式心脏复律除颤器的体验：定性系统评价。
J Adv Nurs. 2011 Dec;67(12):2537-50. doi: 10.1111/j.1365-2648.2011.05694.x. Epub 2011 May 25.

本文引用的文献

1
Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: preliminary Enlighten study results and meta-analysis.血管外植入式心脏复律除颤器上市后研究的围手术期结果：初步的Enlighten研究结果及荟萃分析。
Heart Rhythm. 2025 Mar 17. doi: 10.1016/j.hrthm.2025.02.012.
2
Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention.植入式心脏复律除颤器治疗儿科患者的一级预防与二级预防。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae245.
3
Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies.
胸骨下除颤导线综合分析：EV ICD Pilot、Pivotal 和持续接入研究的经验。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae225.
4
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.